Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04238988 |
| Title | Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer (MITO CERV 3) |
| Acronym | MITO CERV 3 |
| Recruitment | Unknown status |
| Gender | female |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | Fondazione Policlinico Universitario Agostino Gemelli IRCCS |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ITA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Fondazione Policlinico Universitario A. Gemelli IRCCS | RECRUITING | Rome | 00168 | Italy | Details |